Skip to main content
TipRanks
Go Ultimate75% OFF

Fameglow Holdings Limited (8603) AI Stock Analysis

0 Followers
HK:8603

Fameglow Holdings Limited

(HKEX:8603)

Select Model
Rating:61Neutral
Price Target:HKD 45.00â–²(13.75% Upside)
Action:reiterated
Date:10/21/26

The score is supported by strong technical momentum and improving financial performance, including revenue growth, profitability, lower leverage, and better cash generation. These strengths are offset by substantial valuation risk, compressed margins, and a volatile historical balance-sheet and cash-flow profile.

Positive Factors
Revenue and Profitability RecoveryStrong revenue expansion alongside sustained profitability indicates the business has recovered from earlier losses and is operating at greater scale. Positive EBIT and EBITDA provide an earnings base that can support reinvestment, strengthen financial resilience, and extend the company’s ability to compound results over the next several quarters.
Negative Factors
Margin CompressionFalling gross and operating margins suggest that growth is currently producing less profit from each unit of revenue than in earlier periods. If the pressure persists, it could limit earnings growth, reduce the benefits of scale, and make future profitability more sensitive to costs or changes in business mix.

Fameglow Holdings Limited (8603) vs. iShares MSCI Hong Kong ETF (EWH)

-250%0%250%500%750%1000%1250%HK:8603+1144.03%EWH+9.54%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
HKD 11.71B
Dividend Yield
―
Average Volume (3M)
767.44K
Price to Earnings (P/E)
140.9
Beta (1Y)
-0.80
Revenue Growth
35.50%
EPS Growth
18.53%
Country
Hong Kong
Employees
467
Sector
Consumer Cyclical
Sector Strength
61
Industry
Personal Products & Services

Fameglow Holdings Limited Business Overview & Revenue Model

Company Description

Fameglow Holdings Limited, an investment holding entity, offers a range of non-surgical medical aesthetic services across Hong Kong. These include energy-based procedures, which employ various devices that emit energy onto the skin's surface, and min...

Fameglow Holdings Limited Financial Statement Overview

Summary

Strong revenue growth, a recovery to consistent profitability, reduced leverage, and improving operating cash flow support the score. Margin compression, historical leverage risk, and volatile free cash flow limit the upside.

Income Statement

63Positive

Balance Sheet

58Neutral

Cash Flow

67Positive
Financial statement breakdown
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue845.30M589.79M435.27M299.36M227.58M179.63M
Gross Profit337.12M218.36M388.81M260.89M78.65M154.77M
EBITDA214.07M145.74M118.79M93.66M67.63M40.33M
Net Income77.46M54.64M45.73M40.75M16.37M-8.78M
Balance Sheet
Total Assets456.90M456.90M329.81M194.48M208.14M219.66M
Cash, Cash Equivalents and Short-Term Investments135.09M110.69M40.62M19.31M19.22M1.64M
Total Debt119.18M119.18M92.39M45.55M66.38M94.44M
Total Liabilities249.84M249.84M223.72M134.23M188.64M216.53M
Stockholders Equity207.06M207.06M106.09M60.25M19.50M3.13M
Cash Flow
Free Cash Flow-1.95M45.08M30.14M18.28M41.87M-9.71M
Operating Cash Flow72.88M113.14M83.53M34.80M74.07M24.73M
Investing Cash Flow-32.41M-67.94M-35.31M-6.91M-32.18M-34.45M
Financing Cash Flow12.85M24.87M-26.91M-27.80M-24.31M-28.02M

Fameglow Holdings Limited Technical Analysis

Technical Analysis SentimentPositive
Last Price39.56

Price Trends

50DMA28.80Positive
100DMA22.49Positive
200DMA14.77Positive

Market Momentum

MACD2.76Negative
RSI59.99Neutral
STOCH73.44Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8603, the sentiment is Positive. The current price of 39.56 is above the 20-day moving average (MA) of 35.88, above the 50-day MA of 28.80, and above the 200-day MA of 14.77, indicating a bullish trend. The MACD of 2.76 indicates Negative momentum. The RSI at 59.99 is Neutral, neither overbought nor oversold. The STOCH value of 73.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8603.

Fameglow Holdings Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

HK:8603 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:1830HK:183077OutperformHKD 1.98B11.1043.78%9.21%-14.68%-13.60%
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
HK:8603HK:860361NeutralHKD 32.40B140.8949.08%―35.50%18.53%
HK:0922HK:092257NeutralHKD 219.91M-1.90-13.22%16.16%-16.99%-326.96%
HK:2521HK:252152NeutralHKD 1.75B48.136.47%―2.78%-41.23%
HK:0919HK:091948NeutralHKD 67.84M-37.50-0.93%―-2.31%66.07%
HK:8296HK:829643NeutralHKD 15.12M-0.64-17.95%―-26.00%-188.55%

* Consumer Cyclical Sector Average

Performance Comparison

0%500%1000%HK:8603HK:0919HK:0922HK:1830HK:8296HK:2521Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
HK:8603 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:8603Fameglow Holdings Limited39.5636.511197.05%
HK:0919Modern Healthcare Technology Holdings Limited0.070.002.74%
HK:0922Anxian Yuan China Holdings Limited0.10-0.04-30.77%
HK:1830Perfect Medical Health Management Limited1.580.3528.25%
HK:8296Sino-Life Group Limited0.16-0.21-56.76%
HK:2521Shenghui Cleanness Group Holdings Limited0.900.3873.08%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 21, 2026